BIONET Corp. engages in the cell therapy business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells; and genetic testing services. It also provides storage and application of hematopoietic stem cells; regenerative medicine, analytical testing, clinical and preclinical research, and commercialized cell-derived products; and Exosome, a cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.
Metrics to compare | 1784 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1784PeersSector | |
|---|---|---|---|---|
P/E Ratio | 81.4x | 16.2x | −0.6x | |
PEG Ratio | 3.27 | 0.38 | 0.00 | |
Price/Book | 4.5x | 1.7x | 2.6x | |
Price / LTM Sales | 4.7x | 2.9x | 3.4x | |
Upside (Analyst Target) | - | 28.6% | 41.1% | |
Fair Value Upside | Unlock | 22.5% | 5.3% | Unlock |